BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19338759)

  • 1. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.
    Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM
    Biochem Biophys Res Commun; 2009 Mar; 380(4):818-22. PubMed ID: 19338759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
    Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
    Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice.
    Dobrzyn P; Dobrzyn A; Miyazaki M; Ntambi JM
    J Lipid Res; 2010 Aug; 51(8):2202-10. PubMed ID: 20363835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of hepatic stearoyl-CoA desaturase-1 expression by fucoxanthin via leptin signaling in diabetic/obese KK-A(y) mice.
    Beppu F; Hosokawa M; Yim MJ; Shinoda T; Miyashita K
    Lipids; 2013 May; 48(5):449-55. PubMed ID: 23516000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
    Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
    Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stearoyl-CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes.
    Attie AD; Flowers MT; Flowers JB; Groen AK; Kuipers F; Ntambi JM
    Novartis Found Symp; 2007; 286():47-53; discussion 54-7, 162-3, 196-203. PubMed ID: 18269173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined deletion of SCD1 from adipose tissue and liver does not protect mice from obesity.
    Flowers MT; Ade L; Strable MS; Ntambi JM
    J Lipid Res; 2012 Aug; 53(8):1646-53. PubMed ID: 22669918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global deletion of lipocalin 2 does not reverse high-fat diet-induced obesity resistance in stearoyl-CoA desaturase-1 skin-specific knockout mice.
    Friedlander NJ; Burhans MS; Ade L; O'Neill LM; Chen X; Ntambi JM
    Biochem Biophys Res Commun; 2014 Mar; 445(3):578-83. PubMed ID: 24548407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights into stearoyl-CoA desaturase-1.
    Ntambi JM; Miyazaki M
    Curr Opin Lipidol; 2003 Jun; 14(3):255-61. PubMed ID: 12840656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.
    Ntambi JM; Miyazaki M; Stoehr JP; Lan H; Kendziorski CM; Yandell BS; Song Y; Cohen P; Friedman JM; Attie AD
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11482-6. PubMed ID: 12177411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
    Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
    Dobrzyn A; Ntambi JM
    Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation.
    Sampath H; Ntambi JM
    Ann N Y Acad Sci; 2011 Dec; 1243():47-53. PubMed ID: 22211892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stearoyl-CoA desaturase-1 and the metabolic syndrome.
    Cohen P; Ntambi JM; Friedman JM
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):271-80. PubMed ID: 14683458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global deficiency of stearoyl-CoA desaturase-2 protects against diet-induced adiposity.
    O'Neill LM; Phang YX; Matango M; Shamsuzzaman S; Guo CA; Nelson DW; Yen CE; Ntambi JM
    Biochem Biophys Res Commun; 2020 Jun; 527(3):589-595. PubMed ID: 32423819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of stearoyl-CoA desaturase in the control of metabolism.
    Dobrzyn A; Ntambi JM
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):35-41. PubMed ID: 15941655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.
    MacDonald ML; Singaraja RR; Bissada N; Ruddle P; Watts R; Karasinska JM; Gibson WT; Fievet C; Vance JE; Staels B; Hayden MR
    J Lipid Res; 2008 Jan; 49(1):217-29. PubMed ID: 17960025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance.
    Flowers MT; Miyazaki M; Liu X; Ntambi JM
    J Clin Invest; 2006 Jun; 116(6):1478-81. PubMed ID: 16741573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice.
    Hu CC; Qing K; Chen Y
    Obes Res; 2004 Aug; 12(8):1264-70. PubMed ID: 15340109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.